Skip to content

Drug interactions

Saquinavir + Upadacitinib

Severity: Moderate

Saquinavir and Upadacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Saquinavir, usually given with ritonavir, is a strong CYP3A4 inhibitor and can raise upadacitinib exposure. Higher levels may increase the risk of dose-related adverse effects such as infections, cytopenias and lipid elevations.

What this interaction means in plain words

Saquinavir and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated metabolism of upadacitinib in the liver and gut.

What to do

Use the lower upadacitinib dose recommended in labeling for concurrent strong CYP3A4 inhibitors, and monitor for infections and laboratory abnormalities. Reassess the need for the combination if adverse effects develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Saquinavir and Upadacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Saquinavir with Upadacitinib?

MediHelp rates the interaction as moderate. Saquinavir and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Saquinavir, usually given with ritonavir, is a strong CYP3A4 inhibitor and can raise upadacitinib exposure. Higher levels may increase the risk of dose-related adverse effects such as infections, cytopenias and lipid elevations.

How serious is the interaction between Saquinavir and Upadacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the lower upadacitinib dose recommended in labeling for concurrent strong CYP3A4 inhibitors, and monitor for infections and laboratory abnormalities. Reassess the need for the combination if adverse effects develop.

What other medicines interact with Upadacitinib?

MediHelp also lists interactions of Upadacitinib with, for example, Abrocitinib, Adenovirus types 4 and 7 live, Baricitinib. The full list is on the Upadacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in